Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CRYOPDP Australia
Sydney (Bella Vista), New South Wales, Australia
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
CRYOPDP Australia (formerly Critical Transport Solutions Australia, acquired by Cryoport in 2021) is a market leader in premium healthcare logistics, specializing in temperature- and time-critical transportation for life science, pharmaceutical, medical device, biologics, and clinical trial materials, serving both domestic and international markets[1][2][3][4][6].
- Modalities
- Not applicable
- Industry
- Contract Research Organization
02
Partnerships
Novartis (via Cryoport for clinical trial logistics, e.g., Kymriah supply in Australia)[4]Cell Therapies (via broader Cryoport relationship for advanced therapies support)[4]
Beyond the preview
Go deeper on CRYOPDP Australia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CRYOPDP Australia.